GRAY
Price:
$5.5
Market Cap:
$120.98M
Graybug Vision, Inc., a clinical-stage biopharmaceutical company, focuses on the development of medicines for the treatment of diseases of the retina and optic nerve. The company's lead product candidate is GB-102, an intravitreal injection of a microparticle depot formulation of sunitinib that is in Phase I/IIa and IIb clinical trials for the treatment of wet age-related macular degeneration, as well as in Phase IIa clinical trial to treat diabetic macular edema. It also develops GB-102, for the treatment of diabetic retinopathy; and GB-401, an intravitreally injected implant formulation of a beta-adrenergic receptor inhibitor to treat primary open-angle glaucoma. The company was formerly k...[Read more]
Industry
Biotechnology
IPO Date
2020-09-04
Stock Exchange
NASDAQ
Ticker
GRAY
According to Graybug Vision, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 115.07M. This represents a change of -99.67% compared to the average of 34.75B of the last 4 quarters.
The mean historical Enterprise Value of Graybug Vision, Inc. over the last ten years is 5.59B. The current 115.07M Enterprise Value has changed 105.99% with respect to the historical average. Over the past ten years (40 quarters), GRAY's Enterprise Value was at its highest in in the June 2025 quarter at 40.48B. The Enterprise Value was at its lowest in in the March 2023 quarter at -20270655.00.
Average
5.59B
Median
190.70M
Minimum
-6356000.00
Maximum
30.36B
Discovering the peaks and valleys of Graybug Vision, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 30.36B
Minimum Annual Increase = -477696.53%
Minimum Annual Enterprise Value = -6356000.00
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 30.36B | -477696.53% |
| 2022 | -6356000.00 | -125.00% |
| 2021 | 25.42M | -83.97% |
| 2020 | 158.65M | -28.78% |
| 2019 | 222.75M | -91.93% |
The current Enterprise Value of Graybug Vision, Inc. (GRAY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.13B
5-year avg
6.15B
10-year avg
5.59B
Graybug Vision, Inc.’s Enterprise Value is greater than Kinnate Biopharma Inc. (71.17M), greater than NGM Biopharmaceuticals, Inc. (69.72M), greater than Decibel Therapeutics, Inc. (102.82M), less than Tourmaline Bio, Inc. (1.20B), greater than RVL Pharmaceuticals plc (16.09M), less than Paratek Pharmaceuticals, Inc. (351.99M), less than Sesen Bio, Inc. (127.66M), greater than aTyr Pharma, Inc. (87.32M), greater than Quoin Pharmaceuticals, Ltd. (9.45M), greater than Cyteir Therapeutics, Inc. (-37516738.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 71.17M | $124.99M | |
| 69.72M | $128.53M | |
| 102.82M | $123.37M | |
| 1.20B | $1.23B | |
| 16.09M | $3.14M | |
| 351.99M | $127.83M | |
| 127.66M | $127.96M | |
| 87.32M | $81.11M | |
| 9.45M | $11.12M | |
| -37516738.00 | $108.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Graybug Vision, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Graybug Vision, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Graybug Vision, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Graybug Vision, Inc. (GRAY)?
What is the 3-year average Enterprise Value for Graybug Vision, Inc. (GRAY)?
What is the 5-year average Enterprise Value for Graybug Vision, Inc. (GRAY)?
How does the current Enterprise Value for Graybug Vision, Inc. (GRAY) compare to its historical average?